Financial statements Przedsiębiorstwo Farmaceutyczne Jelfa

Balance sheet of Przedsiębiorstwo Farmaceutyczne Jelfa

Company age:
Age:
23 y. 9 m. 11 d.
Share capital:
Share capital:
27 200 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA

Year
2019
2020
2021
2022
2023
Total assets 1 304 274 146,96 1 325 402 820,56 1 054 650 419,72 1 178 200 601,50 1 157 211 980,67
A. Fixed assets 1 163 577 995,55 781 109 611,31 733 845 450,63 698 570 112,43 643 889 611,87
B. Current assets 140 696 151,41 544 293 209,25 320 804 969,09 479 630 489,07 513 322 368,80
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 1 304 274 146,96 1 325 402 820,56 1 054 650 419,72 1 178 200 601,50 1 157 211 980,67
A. Equity 1 261 959 002,03 1 285 604 504,65 1 007 345 230,03 1 125 691 634,59 1 109 221 636,47
B. Liabilities and provisions for liabilities 42 315 144,93 39 798 315,91 47 305 189,69 52 508 966,91 47 990 344,20
I. Long-term liabilities 0,00 322 593,44 353 162,05 216 251,22 306 786,61
II. Short-term liabilities 28 521 814,76 23 817 763,02 32 371 427,85 40 075 111,52 33 704 514,97
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.